ZA201100616B - Treatment of antibiotic-resistant bacteria infection - Google Patents

Treatment of antibiotic-resistant bacteria infection

Info

Publication number
ZA201100616B
ZA201100616B ZA2011/00616A ZA201100616A ZA201100616B ZA 201100616 B ZA201100616 B ZA 201100616B ZA 2011/00616 A ZA2011/00616 A ZA 2011/00616A ZA 201100616 A ZA201100616 A ZA 201100616A ZA 201100616 B ZA201100616 B ZA 201100616B
Authority
ZA
South Africa
Prior art keywords
antibiotic
treatment
resistant bacteria
bacteria infection
infection
Prior art date
Application number
ZA2011/00616A
Other languages
English (en)
Inventor
Ming-Chu Hsu
Chi-Hsin Richard King
Shu-Jen Chen
Luke Lin
Original Assignee
Taigen Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taigen Biotechnology Co Ltd filed Critical Taigen Biotechnology Co Ltd
Publication of ZA201100616B publication Critical patent/ZA201100616B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA2011/00616A 2008-07-01 2011-01-25 Treatment of antibiotic-resistant bacteria infection ZA201100616B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7729308P 2008-07-01 2008-07-01
PCT/US2008/075549 WO2010002415A1 (en) 2008-07-01 2008-09-08 Treatment of antibiotic-resistant bacteria infection

Publications (1)

Publication Number Publication Date
ZA201100616B true ZA201100616B (en) 2011-10-26

Family

ID=41464848

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/00616A ZA201100616B (en) 2008-07-01 2011-01-25 Treatment of antibiotic-resistant bacteria infection

Country Status (13)

Country Link
US (1) US8211909B2 (enExample)
EP (1) EP2303271B1 (enExample)
JP (1) JP2011526887A (enExample)
KR (2) KR20150006080A (enExample)
CN (1) CN101618038B (enExample)
AU (1) AU2008358909B2 (enExample)
CA (1) CA2728328C (enExample)
EA (1) EA018653B1 (enExample)
NZ (1) NZ588898A (enExample)
TR (1) TR201820964T4 (enExample)
TW (1) TWI375558B (enExample)
WO (1) WO2010002415A1 (enExample)
ZA (1) ZA201100616B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101392808B1 (ko) * 2011-12-30 2014-05-12 순천대학교 산학협력단 식물 추출물 또는 이의 분획물을 포함하는 항균용 조성물
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
KR101392810B1 (ko) * 2013-09-25 2014-05-12 순천대학교 산학협력단 된장풀 추출물 또는 이의 분획물을 포함하는 항균용 조성물
US9492374B2 (en) 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
CN105368825B (zh) * 2015-10-14 2019-09-10 华东医院 幽门螺杆菌抗生素耐药性分析试剂盒及耐药性检测方法
US12358902B2 (en) * 2017-12-11 2025-07-15 Denovamed Inc. 5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infections
CN111979292B (zh) * 2020-07-27 2022-08-05 广东省微生物研究所（广东省微生物分析检测中心） 一种同时携带多重耐药基因cfr和lsa(E)的MRSA的用途
CN114437026A (zh) * 2021-10-26 2022-05-06 浙江医药股份有限公司新昌制药厂 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法
CN118852222B (zh) * 2024-06-27 2025-09-05 南京桦冠生物技术有限公司 一种奈诺沙星中间体及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100800A (en) 1870-03-15 Improvement in riding attachments for plows
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
EP1015445B1 (en) 1997-09-15 2009-02-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
US6348624B1 (en) 1998-01-09 2002-02-19 The Procter & Gamble Co. Process for making certain benzoic acid compounds
DK1343766T3 (da) 2000-12-14 2005-10-31 Procter & Gamble Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
DK2001862T3 (da) 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
JP4876165B2 (ja) 2006-03-28 2012-02-15 ザ プロクター アンド ギャンブル カンパニー キノロン中間体を調製するための水素化物還元法
BRPI0709220A2 (pt) * 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
US20120157492A1 (en) 2008-07-15 2012-06-21 Taigen Biotechnology Co., Ltd. Antibiotic drug

Also Published As

Publication number Publication date
EA201170121A1 (ru) 2011-06-30
EP2303271B1 (en) 2018-11-07
US8211909B2 (en) 2012-07-03
JP2011526887A (ja) 2011-10-20
HK1139049A1 (en) 2010-09-10
TWI375558B (en) 2012-11-01
EP2303271A1 (en) 2011-04-06
CN101618038A (zh) 2010-01-06
EA018653B1 (ru) 2013-09-30
NZ588898A (en) 2012-09-28
TR201820964T4 (tr) 2019-01-21
EP2303271A4 (en) 2012-01-25
TW201002322A (en) 2010-01-16
CA2728328C (en) 2015-02-24
WO2010002415A1 (en) 2010-01-07
CN101618038B (zh) 2011-12-07
US20100004282A1 (en) 2010-01-07
AU2008358909B2 (en) 2012-12-13
KR20110044168A (ko) 2011-04-28
CA2728328A1 (en) 2010-01-07
KR20150006080A (ko) 2015-01-15
AU2008358909A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
ZA201005798B (en) Treatment of microbial infections
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
ZA200906126B (en) Use of IL-23 antigonists for treatment of infection
ZA201100616B (en) Treatment of antibiotic-resistant bacteria infection
GB0818074D0 (en) Treatment of biofilms
ZA201100705B (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
EP2509622A4 (en) INHIBITION OF BACTERIAL INFECTIONS AND BIOFILM FORMATION
GB201107350D0 (en) Topical treatment of skin infection
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
ZA201107903B (en) Methods of treating a pulmonary bacterial infection using fluoro-quinolones
ZA201206204B (en) Treatment or prevention of infection
PL2435026T3 (pl) Leczenie zrostu tkanek
EP2417258A4 (en) BACTERIOPHAGE COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
ZA201204249B (en) Treatment of microbial infections
WO2011146624A9 (en) Methods of treating recurring bacterial infection
GB0723100D0 (en) Treatment of HFnEF
IL227132B (en) An antibacterial agent for the treatment of infectious diseases of bacterial origin
GB0807781D0 (en) Treatment of bacterial infection
GB0908964D0 (en) Treatment of pathogenic infection
AU2009900969A0 (en) Treatment of infection
GB0801768D0 (en) Treatment of microbial infections
GB0813716D0 (en) Treatment of viral infection
GB2442705B (en) Inactivation of gram-positive bacteria
GB0909811D0 (en) Treatment of parasitic infection
HK1177147A (en) Treatment or prevention of infection